Evidence map›Paper›PMID 16511562›Full record

ArticleThe EMBO journal2006

Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor.

Kristopher K Frese, Isabel J Latorre, Sang-Hyuk Chung, Georgina Caruana, Alan Bernstein, Stephen N Jones, Lawrence A Donehower, Monica J Justice, Craig C Garner, Ronald T Javier

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Polarity scaffolds signaling in epithelial cell permeability.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  3. PDZ Domains as Drug Targets.Advanced therapeutics · 2019
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Kristopher K FreseDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Isabel J Latorre
Sang-Hyuk Chung
Georgina Caruana
Alan Bernstein
Stephen N Jones
Lawrence A Donehower
Monica J Justice
Craig C Garner
Ronald T Javier
Baylor College of Medicine · USLunenfeld-Tanenbaum Research Institute · CAMonash University · AUStanford University · USUniversity of Massachusetts Chan Medical School · US

Funding

ROLE OF THE AD9 E4 REGION IN MAMMARY GLAND ONCOGENESISR01CA058541 · NCI · BAYLOR COLLEGE OF MEDICINE · PI JAVIER, RONALD T. · 1993 to 2013
$3.9M
RESEARCH TRAINING PROGRAM IN VIRAL ONCOLOGYT32CA009197 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MARRIOTT, SUSAN J · 1986 to 2003
$804k
NCI NIH HHS R01 CA058541NCI NIH HHS R01 CA58541NCI NIH HHS T32 CA009197NCI NIH HHS T32 CA09197
6 · The paper itself

Abstract

The fact that several different human virus oncoproteins, including adenovirus type 9 E4-ORF1, evolved to target the Dlg1 mammalian homolog of the membrane-associated Drosophila discs-large tumor suppressor has implicated this cellular factor in human cancer. Despite a general belief that such interactions function solely to inactivate this suspected human tumor suppressor protein, we demonstrate here that E4-ORF1 specifically requires endogenous Dlg1 to provoke oncogenic activation of phosphatidylinositol 3-kinase (PI3K) in cells. Based on our results, we propose a model wherein E4-ORF1 binding to Dlg1 triggers the resulting complex to translocate to the plasma membrane and, at this site, to promote Ras-mediated PI3K activation. These findings establish the first known function for Dlg1 in virus-mediated cellular transformation and also surprisingly expose a previously unrecognized oncogenic activity encoded by this suspected cellular tumor suppressor gene.

Indexed as

Cell Transformation, ViralAnimalsCell MembraneClass I Phosphatidylinositol 3-KinasesDiscs Large Homolog 1 ProteinGenes, rasHumansMiceNerve Tissue ProteinsOncogene Proteins, ViralPhosphatidylinositol 3-KinasesProtein TransportSAP90-PSD95 Associated ProteinsTransfectionTumor Suppressor ProteinsClass I Phosphatidylinositol 3-KinasesDiscs Large Homolog 1 ProteinDlg1 protein, mouseE4 protein, Adenovirus 9Nerve Tissue ProteinsOncogene Proteins, ViralPhosphatidylinositol 3-KinasesPIK3CA protein, humanSAP90-PSD95 Associated ProteinsTumor Suppressor Proteins

Identifiers

PMID16511562
PMCPMC1422156
OpenAlexW2101691933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.